Cas12蛋白全球市场报告（2025年）

近年来，Cas12蛋白的市场规模迅速扩张，预计将从2024年的19.5亿美元成长到2025年的22.6亿美元，复合年增长率达15.9%。预测期内的成长可归因于政府对生物技术和基因工程倡议的投资增加、发展中地区对照护现场解决方案的需求不断增长、Cas12系统与次世代定序平台的整合日益广泛、人们对疾病早期检测和预防策略的兴趣日益浓厚，以及蛋白质工程技术的进步提高了Cas12的特异性。

预计未来几年Cas12蛋白市场将快速成长，到2029年市场规模将达到40.3亿美元，复合年增长率（CAGR）为15.5%。预测期内的成长主要归因于遗传疾病盛行率的上升、基因编辑研发投入的增加、个人化医疗意识的增强、对快速精准感染疾病诊断需求的增长，以及Cas12蛋白在农业生物技术中用于作物增产的广泛应用。预测期内的关键趋势包括与其他CRISPR组件的整合、基因编辑递送技术的进步、修饰型Cas12蛋白的开发、诊断平台技术的改进以及生物资讯工具的进步。

Cas12蛋白是一种与成簇规律间隔短丛集重复序列（CRISPR）相关的酶，在基因编辑和分子诊断中发挥重要作用。在CRISPR RNA的引导下，Cas12能够寻找并精确地切割特定的DNA序列。其额外的切割活性也使其可用于快速灵敏的诊断应用。

Cas12蛋白主要分为天然Cas12蛋白、工程化Cas12蛋白、与其他CRISPR组分整合的Cas12蛋白。天然Cas12蛋白是细菌酶，能够辨识并切割特定的DNA序列，是CRISPR免疫防御系统的一部分。这些蛋白质有多种製剂形式，包括液体、冷冻干燥粉和质体衍生形式。常用的递送方法包括病毒载体、脂质奈米颗粒、电穿孔和显微注射。 Cas12蛋白广泛应用于基因组编辑、基因敲除、基因调控、基因工程和治疗药物研发等领域，服务终端用户包括学术和研究机构、製药和生物技术公司、诊断实验室以及农业企业等。

2025年，美国关税的突然上调及其引发的贸易摩擦对製药公司造成了严重衝击。利润率高的学名药生产商尤其脆弱，一些公司不得不缩减低收益药物的生产规模。生物技术公司也因关税导致的专用试剂短缺而面临临床试验延期。为因应这一局面，製药业正在印度和欧洲扩大原料药的生产，增加库存，并游说政府对基本药物给予贸易豁免。

这份Cas12蛋白市场研究报告是商业研究公司最新系列报告的一部分，提供Cas12蛋白市场统计数据，例如全球市场规模、区域份额、占据Cas12蛋白市场份额的竞争对手、详细的Cas12蛋白市场细分、市场趋势以及Cas12蛋白行业的商业机会。本市场研究报告对该行业的现状和未来发展趋势进行了详细分析，为您提供所需的一切全面观点。

预计未来几年，遗传疾病盛行率的上升将推动Cas12蛋白市场的成长。遗传疾病是由个体DNA的突变或改变引起的，这些突变或改变会扰乱正常的身体功能。遗传疾病发生率的上升与近亲结婚率的上升密切相关，近亲结婚会增加遗传疾病的风险。 Cas12蛋白能够精准靶向特定位点，切割DNA并纠正、移除或替换缺陷基因，从而实现针对遗传疾病的精准基因治疗，同时最大限度地减少脱靶效应。例如，英国国家医疗服务体系（NHS）在2024年5月报告称，英格兰约有17,000人患有镰状细胞贫血症（一种镰状血液疾病），每年新增病例约250例。因此，遗传疾病盛行率的上升正在推动对Cas12蛋白市场的需求。

Cas12蛋白市场的主要企业正在采取策略性措施，例如股权投资，以加速创新并扩展其基因编辑能力。股权投资是指购买公司的股份或所有权，使投资者获得部分所有权，并有可能根据公司的业绩获得回报。例如，2024年4月，美国生技公司Regeneron Pharmaceuticals向Mammoth Biosciences投资1亿美元，利用Mammoth Biosciences的超小型CRISPR酶，透过腺结合病毒（AAV）在除肝臟以外的多种组织中进行体内基因编辑治疗。透过将Mammoth Biosciences的超小型CRISPR酶与Regeneron先进的AAV递送系统相结合，该合作实现了精准高效的体内基因编辑。这项合作将为Mammoth Biosciences提供资金、里程碑付款和特许权使用费，同时使Regeneron在五年多的时间里独家使用先进的基因编辑工具，从而加速开发针对更广泛疾病的下一代基因药物。

2023年8月，中国生技公司汇基生物科技有限公司与凯克生物技术有限公司达成合作，共同开发一种针对罕见遗传疾病的新型基因编辑疗法。此次合作旨在加速汇基高精度基因编辑酶hfCas12Max在大中华区的商业化和GMP生产，并将充分利用凯克生物技术在下一代基因组药物开发方面的专业技术。凯克生物技术是一家专注于Cas12蛋白生产的中国公司。

Cas12蛋白市场包括分子诊断套件、科研试剂和生物感测器的销售。该市场的价值为“出厂价”，即製造商或产品创造者向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的产品的价值。该市场的产品价值还包括产品创造者提供的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球Cas12蛋白：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
• 终端用户产业分析
• 全球Cas12蛋白市场：成长率分析
• 全球Cas12蛋白市场表现：规模与成长，2019-2024年
• 全球Cas12蛋白市场预测：规模与成长，2024-2029年，2034年
• 全球 Cas12 蛋白：潜在市场规模 (TAM)

第六章 市场细分

• 全球Cas12蛋白市场按类型、性能和预测划分，2019-2024年、2024-2029年、2034年
• 天然Cas12蛋白
• 修饰的Cas12蛋白
• 与其他CRISPR组件的集成
• 全球Cas12蛋白市场：依配方、效能和预测划分，2019-2024年、2024-2029年和2034年
• 液体製剂
• 冻干粉
• 质体衍生
• 全球Cas12蛋白市场依递送方式划分：效能及预测，2019-2024年、2024-2029年、2034年
• 病毒载体
• 脂质奈米颗粒
• 电穿孔
• 显微注射
• 全球Cas12蛋白市场：依应用、效能和预测划分，2019-2024年、2024-2029年、2034年
• 基因组编辑
• 基因敲除
• 基因调控
• 基因工程
• 治疗药物研发
• 全球Cas12蛋白市场依最终用户、效能和预测划分，2019-2024年、2024-2029年、2034年
• 学术和研究机构
• 製药和生物技术公司
• 诊断实验室
• 农业企业
• 全球 Cas12 蛋白市场：天然 Cas12 蛋白细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
• Cas12a
• Cas12b
• Cas12c
• 全球Cas12蛋白市场：修饰型Cas12蛋白细分市场，按类型、性能和预测（2019-2024年、2024-2029年、2034年）
• 工程改造的Cas12变体
• 高保真Cas12蛋白
• Cas12融合蛋白
• 全球 Cas12 蛋白市场：与其他 CRISPR 组件整合细分市场，按类型划分，实际数据和预测数据，2019-2024 年、2024-2029 年、2034 年
• Cas12 和 Cas9 系统
• Cas12 和碱基编辑器
• Cas12 与 Prime Editor

第七章 区域和国家分析

• 全球Cas12蛋白市场：按地区、表现和预测划分，2019-2024年、2024-2029年、2034年
• 全球Cas12蛋白市场：依国家、效能和预测划分，2019-2024年、2024-2029年、2034年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

• Cas12蛋白市场：竞争格局
• Cas12蛋白市场：公司概况
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bio-Techne Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Integrated DNA Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • GenScript Biotech Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Takara Bio Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

• Abcam plc
• Aldevron LLC
• New England Biolabs Inc.
• Cusabio Biotech Co. Ltd.
• Synthego Corporation
• ABclonal Technology Co. Ltd.
• Mammoth Biosciences Inc.
• Rockland Immunochemicals Inc.
• Creative BioMart
• Editas Medicine Inc.
• VectorBuilder
• Sherlock Biosciences
• Biomatik
• SBS Genetech Co. Ltd.
• ProSpec-Tany Technogene Ltd.

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

• Cas12蛋白市场展望2029：提供新机会的国家
• Cas12蛋白市场展望2029：新兴细分市场蕴藏新的机会
• Cas12蛋白市场2029：成长策略
  • 基于市场趋势的策略
  • 竞争对手策略

第36章附录

Cas12 protein is an enzyme associated with clustered regularly interspaced short palindromic repeats (CRISPR) that plays a crucial role in gene editing and molecular diagnostics. Guided by CRISPR RNA, Cas12 locates specific DNA sequences and cleaves them precisely, allowing for targeted genetic modifications. Its collateral cleavage activity also makes it valuable for rapid and sensitive diagnostic applications.

The primary types of Cas12 protein include natural Cas12 proteins, modified Cas12 proteins, and those integrated with other CRISPR components. Natural Cas12 proteins are bacterial enzymes that identify and cut specific DNA sequences as part of the CRISPR immune defense system. These proteins are available in different formulations, such as liquid, lyophilized powder, and plasmid-derived forms. Common delivery methods include viral vectors, lipid nanoparticles, electroporation, and microinjection. Cas12 proteins are widely used in applications such as genome editing, gene knockout, gene regulation, genetic engineering, and therapeutic development, serving end users including academic and research institutions, pharmaceutical and biotechnology companies, diagnostic laboratories, and agricultural organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The Cas12 protein market research report is one of a series of new reports from The Business Research Company that provides Cas12 protein market statistics, including Cas12 protein industry global market size, regional shares, competitors with a Cas12 protein market share, detailed Cas12 protein market segments, market trends and opportunities, and any further data you may need to thrive in the Cas12 protein industry. This Cas12 protein market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The Cas12 protein market size has grown rapidly in recent years. It will grow from $1.95 billion in 2024 to $2.26 billion in 2025 at a compound annual growth rate (CAGR) of 15.9%. The growth in the historic period can be attributed to rising government investments in biotechnology and genetic engineering initiatives, increasing demand for point-of-care diagnostic solutions in developing regions, expanding integration of Cas12 systems into next-generation sequencing platforms, heightened focus on early disease detection and prevention strategies, and advancing protein engineering techniques that improve Cas12 specificity.

The Cas12 protein market size is expected to see rapid growth in the next few years. It will grow to $4.03 billion in 2029 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to the rising prevalence of genetic disorders, increasing investment in gene-editing research and development, growing awareness of personalized medicine, higher demand for rapid and precise infectious disease diagnostics, and expanding use of Cas12 proteins in agricultural biotechnology for crop enhancement. Key trends in the forecast period include integration with other CRISPR components, advancements in gene-editing delivery technologies, development of modified Cas12 proteins, technological improvements in diagnostic platforms, and progress in bioinformatics tools.

The rising prevalence of genetic diseases is expected to drive the growth of the Cas12 protein market in the coming years. Genetic diseases are caused by mutations or changes in an individual's DNA that disrupt normal bodily functions. Their increasing incidence is linked to the rising rate of consanguineous marriages, which heightens the likelihood of inheriting genetic disorders. Cas12 proteins precisely target and cut DNA at specific sites to correct, remove, or replace faulty genes, enabling highly accurate gene therapies for inherited conditions with minimal off-target effects. For example, in May 2024, the National Health Service, a UK-based government department, reported that approximately 17,000 people in England live with sickle cell disease, an inherited blood disorder, with around 250 new cases diagnosed annually. Consequently, the growing prevalence of genetic diseases is fueling demand in the Cas12 protein market.

Key companies in the Cas12 protein market are adopting strategic approaches, such as equity investments, to accelerate innovation and expand gene-editing capabilities. Equity investment involves purchasing shares or ownership stakes in a company, giving investors partial ownership and potential returns based on company performance. For instance, in April 2024, Regeneron Pharmaceuticals, Inc., a US-based biotechnology company, invested $100 million in Mammoth Biosciences to access their ultracompact CRISPR enzymes for in vivo gene editing therapies using adeno-associated viruses (AAVs) across multiple tissues beyond the liver. By combining Mammoth's ultracompact CRISPR enzymes with Regeneron's advanced AAV delivery system, the partnership enables precise and efficient in vivo editing. This collaboration provides Mammoth with funding, milestones, and royalties, while Regeneron gains exclusive access to advanced gene-editing tools for over five years, collectively accelerating next-generation genetic medicines for a broader range of diseases.

In August 2023, Hui-Gene Therapeutics Co., Ltd., a China-based biotechnology company, partnered with Kactus Biotechnology to develop novel gene-editing therapies targeting rare genetic disorders. The collaboration aims to fast-track commercialization and GMP manufacturing of Hui-Gene's high-precision gene-editing enzyme hfCas12Max in Greater China, leveraging Kactus Bio's expertise to advance next-generation genome medicines. Kactus Biotechnology is a China-based company specializing in the production of Cas12 proteins.

Major players in the cas12 protein market are Thermo Fisher Scientific Inc., Bio-Techne Corporation, Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio Inc., Abcam plc, Aldevron LLC, New England Biolabs Inc., Cusabio Biotech Co. Ltd., Synthego Corporation, ABclonal Technology Co. Ltd., Mammoth Biosciences Inc., Rockland Immunochemicals Inc., Creative BioMart, Editas Medicine Inc., VectorBuilder, Sherlock Biosciences, Biomatik, SBS Genetech Co. Ltd., ProSpec-Tany Technogene Ltd., Inscripta Inc., Addgene Inc.

North America was the largest region in the Cas12 protein market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in Cas12 protein market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the Cas12 protein market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The Cas12 protein market consists of sales of molecular diagnostic kits, research reagents, and biosensors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cas12 Protein Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cas12 protein market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cas12 protein ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cas12 protein market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Natural Cas12 Proteins; Modified Cas12 Proteins; Integration With Other Crispr Components
• 2) By Formulation: Liquid Formulations; Lyophilized Powder; Plasmid-Derived Cas12 Proteins
• 3) By Delivery Method: Viral Vectors; Lipid Nanoparticles; Electroporation; Microinjection
• 4) By Application: Genome Editing; Gene Knockout; Gene Regulation; Genetic Engineering; Therapeutics Development
• 5) By End User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Diagnostic Laboratories; Agricultural Companies
• Subsegments:
• 1) By Natural Cas12 Proteins: Cas12a; Cas12b; Cas12c
• 2) By Modified Cas12 Proteins: Engineered Cas12 Variants; High-Fidelity Cas12 Proteins; Fusion Proteins With Cas12
• 3) By Integration With Other CRISPR Components: Cas12 With Cas9 Systems; Cas12 With Base Editors; Cas12 With Prime Editors
• Companies Mentioned: Thermo Fisher Scientific Inc.; Bio-Techne Corporation; Integrated DNA Technologies Inc.; GenScript Biotech Corporation; Takara Bio Inc.; Abcam plc; Aldevron LLC; New England Biolabs Inc.; Cusabio Biotech Co. Ltd.; Synthego Corporation; ABclonal Technology Co. Ltd.; Mammoth Biosciences Inc.; Rockland Immunochemicals Inc.; Creative BioMart; Editas Medicine Inc.; VectorBuilder; Sherlock Biosciences; Biomatik; SBS Genetech Co. Ltd.; ProSpec-Tany Technogene Ltd.; Inscripta Inc.; Addgene Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cas12 Protein Market Characteristics

3. Cas12 Protein Market Trends And Strategies

4. Cas12 Protein Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cas12 Protein Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cas12 Protein PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cas12 Protein Market Growth Rate Analysis
• 5.4. Global Cas12 Protein Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cas12 Protein Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cas12 Protein Total Addressable Market (TAM)

6. Cas12 Protein Market Segmentation

• 6.1. Global Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Natural Cas12 Proteins
• Modified Cas12 Proteins
• Integration With Other Crispr Components
• 6.2. Global Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liquid Formulations
• Lyophilized Powder
• Plasmid-Derived Cas12 Proteins
• 6.3. Global Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Viral Vectors
• Lipid Nanoparticles
• Electroporation
• Microinjection
• 6.4. Global Cas12 Protein Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genome Editing
• Gene Knockout
• Gene Regulation
• Genetic Engineering
• Therapeutics Development
• 6.5. Global Cas12 Protein Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Academic And Research Institutes
• Pharmaceutical And Biotechnology Companies
• Diagnostic Laboratories
• Agricultural Companies
• 6.6. Global Cas12 Protein Market, Sub-Segmentation Of Natural Cas12 Proteins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cas12a
• Cas12b
• Cas12c
• 6.7. Global Cas12 Protein Market, Sub-Segmentation Of Modified Cas12 Proteins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Engineered Cas12 Variants
• High-Fidelity Cas12 Proteins
• Fusion Proteins With Cas12
• 6.8. Global Cas12 Protein Market, Sub-Segmentation Of Integration With Other CRISPR Components, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cas12 With Cas9 Systems
• Cas12 With Base Editors
• Cas12 With Prime Editors

7. Cas12 Protein Market Regional And Country Analysis

• 7.1. Global Cas12 Protein Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cas12 Protein Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cas12 Protein Market

• 8.1. Asia-Pacific Cas12 Protein Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cas12 Protein Market

• 9.1. China Cas12 Protein Market Overview
• 9.2. China Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cas12 Protein Market

• 10.1. India Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cas12 Protein Market

• 11.1. Japan Cas12 Protein Market Overview
• 11.2. Japan Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cas12 Protein Market

• 12.1. Australia Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cas12 Protein Market

• 13.1. Indonesia Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cas12 Protein Market

• 14.1. South Korea Cas12 Protein Market Overview
• 14.2. South Korea Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cas12 Protein Market

• 15.1. Western Europe Cas12 Protein Market Overview
• 15.2. Western Europe Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cas12 Protein Market

• 16.1. UK Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cas12 Protein Market

• 17.1. Germany Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cas12 Protein Market

• 18.1. France Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cas12 Protein Market

• 19.1. Italy Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cas12 Protein Market

• 20.1. Spain Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cas12 Protein Market

• 21.1. Eastern Europe Cas12 Protein Market Overview
• 21.2. Eastern Europe Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cas12 Protein Market

• 22.1. Russia Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cas12 Protein Market

• 23.1. North America Cas12 Protein Market Overview
• 23.2. North America Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cas12 Protein Market

• 24.1. USA Cas12 Protein Market Overview
• 24.2. USA Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cas12 Protein Market

• 25.1. Canada Cas12 Protein Market Overview
• 25.2. Canada Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cas12 Protein Market

• 26.1. South America Cas12 Protein Market Overview
• 26.2. South America Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cas12 Protein Market

• 27.1. Brazil Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cas12 Protein Market

• 28.1. Middle East Cas12 Protein Market Overview
• 28.2. Middle East Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cas12 Protein Market

• 29.1. Africa Cas12 Protein Market Overview
• 29.2. Africa Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cas12 Protein Market Competitive Landscape And Company Profiles

• 30.1. Cas12 Protein Market Competitive Landscape
• 30.2. Cas12 Protein Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bio-Techne Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Integrated DNA Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GenScript Biotech Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Takara Bio Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cas12 Protein Market Other Major And Innovative Companies

• 31.1. Abcam plc
• 31.2. Aldevron LLC
• 31.3. New England Biolabs Inc.
• 31.4. Cusabio Biotech Co. Ltd.
• 31.5. Synthego Corporation
• 31.6. ABclonal Technology Co. Ltd.
• 31.7. Mammoth Biosciences Inc.
• 31.8. Rockland Immunochemicals Inc.
• 31.9. Creative BioMart
• 31.10. Editas Medicine Inc.
• 31.11. VectorBuilder
• 31.12. Sherlock Biosciences
• 31.13. Biomatik
• 31.14. SBS Genetech Co. Ltd.
• 31.15. ProSpec-Tany Technogene Ltd.

32. Global Cas12 Protein Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cas12 Protein Market

34. Recent Developments In The Cas12 Protein Market

35. Cas12 Protein Market High Potential Countries, Segments and Strategies

• 35.1 Cas12 Protein Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cas12 Protein Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cas12 Protein Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer